Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Nostopharma LLC
Profile last edited on: 3/12/2023      CAGE: 7ZZH1      UEI: FKVPNPQK64H8

Business Identifier: Provides pathologic bone growth treatment intended to prevent rare bone disease
Year Founded
2016
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

7600 Coddle Harbor Lane
Potomac, MD 20854
   (703) 679-0048
   info@nostopharma.com
   www.nostopharma.com
Location: Single
Congr. District: 08
County: Montgomery

Public Profile

Nostopharma LLC is a provider of pathologic bone growth treatment intended to prevent rare bone disease. The company's treatment assists patients form new bone following surgeries, burns, injuries and other traumas, enabling healthcare providers to cure their patients.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$256,000
Phase II Dollars
$0
Total Awarded
$256,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NSF $256,000
Project Title: Improved Drug Delivery Platforms for Localized and Sustained Drug Deposition for Traumatic Injuries
0 1 NIH $318,796
Project Title: Small molecules combination therapy using polypharmacology approach as a novel treatment paradigm for rare bone disease

Key People / Management

  Katya Vert -- Co-Founder & CEO

  Stephen E Hoag -- Professor at Dept. of Pharmaceutical Sciences

  Jelena Gvozdenovic Jeremic -- Co-Founder & CSO

  Anthony G Sanzone -- Orthopaedic Surgeon

Company News

There are no news available.